Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Deficit, Unaudited

v3.23.2
Condensed Consolidated Statement of Stockholders' Deficit, Unaudited - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 355,301 $ 118,065,699 $ (122,594,000) $ (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 367 5,633 6,000
Common stock issued on conversion of notes payable, shares 366,666      
Common stock issued on exercise of warrants $ 3,260 94,740 98,000
Common stock issued on exercise of warrants, shares 3,260,000      
Fair value of options and warrants issued as compensation 27,000 27,000
Net loss (472,000) (472,000)
Ending balance, value at Jun. 30, 2022 $ 358,928 118,193,072 (123,066,000) (4,514,000)
Balance at ending, shares at Jun. 30, 2022 358,926,888      
Beginning balance, value at Mar. 31, 2022 $ 356,493 118,119,507 (122,895,000) (4,419,000)
Balance at beginning, shares at Mar. 31, 2022 356,491,888      
Common stock issued on exercise of warrants $ 2,435 70,565 73,000
Common stock issued on exercise of warrants, shares 2,435,000      
Fair value of options and warrants issued as compensation 3,000 3,000
Net loss (171,000) (171,000)
Ending balance, value at Jun. 30, 2022 $ 358,928 118,193,072 (123,066,000) (4,514,000)
Balance at ending, shares at Jun. 30, 2022 358,926,888      
Beginning balance, value at Dec. 31, 2022 $ 376,075 119,075,925 (124,142,000) (4,690,000)
Balance at beginning, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 8,629 161,371 170,000
Common stock issued on conversion of notes payable, shares 8,628,664      
Relative fair value of warrants issued with convertible notes 103,000 103,000
Common stock issued on exercise of warrants $ 1,117 40,883 42,000
Common stock issued on exercise of warrants, shares 1,116,662      
Fair value of options and warrants issued as compensation 14,000 14,000
Net loss (618,000) (618,000)
Ending balance, value at Jun. 30, 2023 $ 385,821 119,395,179 (124,760,000) (4,979,000)
Balance at ending, shares at Jun. 30, 2023 385,819,422      
Beginning balance, value at Mar. 31, 2023 $ 384,538 119,306,462 (124,476,000) (4,785,000)
Balance at beginning, shares at Mar. 31, 2023 384,537,426      
Common stock issued on conversion of notes payable $ 1,149 24,851 26,000
Common stock issued on conversion of notes payable, shares 1,148,664      
Relative fair value of warrants issued with convertible notes 56,000 56,000
Common stock issued on exercise of warrants $ 134 2,866 3,000
Common stock issued on exercise of warrants, shares 133,332      
Fair value of options and warrants issued as compensation 5,000 5,000
Net loss (284,000) (284,000)
Ending balance, value at Jun. 30, 2023 $ 385,821 $ 119,395,179 $ (124,760,000) $ (4,979,000)
Balance at ending, shares at Jun. 30, 2023 385,819,422